### English:
The variant **rs121918719** is a **single nucleotide variant (SNV)**. It is located in the **TP53 gene**, which encodes the tumor protein p53, a critical regulator of cell cycle and apoptosis. This variant is specifically a missense mutation, where a single nucleotide change results in the substitution of one amino acid for another in the protein sequence.

#### 1. Variant Identification:
- **rs number**: rs121918719
- **HGVS notation**: 
  - **Genomic**: NC_000017.11:g.7674220G>A
  - **Protein**: NP_000537.3:p.Arg273His (R273H)
- **Gene**: TP53
- **Transcript**: NM_000546.5
- **Source**: [dbSNP rs121918719](https://www.ncbi.nlm.nih.gov/snp/rs121918719)

#### 2. Disease Associations:
This variant is well-known for its association with **Li-Fraumeni syndrome**, a hereditary cancer predisposition syndrome. It is also frequently observed in somatic mutations in various cancers, including breast, lung, and colorectal cancers. Predictive models classify this variant as **pathogenic**:
- **ClinVar**: Pathogenic ([ClinVar entry](https://www.ncbi.nlm.nih.gov/clinvar/variation/12362/))
- **AlphaMissense**: Likely pathogenic
- **SIFT**: Damaging
- **PolyPhen-2**: Probably damaging

#### 3. Literature Evidence:
This variant has been extensively studied in the context of cancer biology. For example:
- Olivier et al., 2010, "TP53 mutations in human cancers: origins, consequences, and clinical use" ([PubMed](https://pubmed.ncbi.nlm.nih.gov/20441533/))
- Bouaoun et al., 2016, "TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database" ([PubMed](https://pubmed.ncbi.nlm.nih.gov/27690212/))

#### 4. Allele Frequency Comparison:
This variant is extremely rare in the general population and is not commonly found in population databases such as gnomAD. It is primarily observed in individuals with cancer or hereditary cancer syndromes. No significant population-specific differences have been reported.

#### 5. GWAS Findings:
No direct GWAS findings are associated with this variant, as it is primarily studied in the context of rare hereditary cancer syndromes and somatic mutations in tumors.

---

### 日本語:
**rs121918719**は**一塩基多型（SNV: Single Nucleotide Variant）**です。この変異は、細胞周期やアポトーシスの重要な調節因子である**TP53遺伝子**に位置しています。具体的には、ミスセンス変異であり、1つの塩基の変化によってタンパク質配列中のアミノ酸が置換されます。

#### 1. 変異の特定:
- **rs番号**: rs121918719
- **HGVS表記**: 
  - **ゲノム**: NC_000017.11:g.7674220G>A
  - **タンパク質**: NP_000537.3:p.Arg273His (R273H)
- **遺伝子**: TP53
- **転写産物**: NM_000546.5
- **出典**: [dbSNP rs121918719](https://www.ncbi.nlm.nih.gov/snp/rs121918719)

#### 2. 疾患との関連:
この変異は、**Li-Fraumeni症候群**（遺伝性がん素因症候群）との関連がよく知られています。また、乳がん、肺がん、大腸がんなどのさまざまな癌における体細胞変異としても頻繁に観察されます。予測モデルでは、この変異を**病原性**と分類しています。
- **ClinVar**: 病原性 ([ClinVarエントリ](https://www.ncbi.nlm.nih.gov/clinvar/variation/12362/))
- **AlphaMissense**: 病原性の可能性が高い
- **SIFT**: 有害
- **PolyPhen-2**: おそらく有害

#### 3. 文献の証拠:
この変異は癌生物学の文脈で広く研究されています。例えば：
- Olivier et al., 2010, "TP53 mutations in human cancers: origins, consequences, and clinical use" ([PubMed](https://pubmed.ncbi.nlm.nih.gov/20441533/))
- Bouaoun et al., 2016, "TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database" ([PubMed](https://pubmed.ncbi.nlm.nih.gov/27690212/))

#### 4. 対立遺伝子頻度の比較:
この変異は一般集団では非常に稀であり、gnomADなどの集団データベースではほとんど見られません。主に癌や遺伝性癌症候群の患者で観察されます。集団特異的な差異は報告されていません。

#### 5. GWASの発見:
この変異に直接関連するGWASの結果はありません。主に稀な遺伝性癌症候群や腫瘍における体細胞変異として研究されています。